Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
about
Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSDirectly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trialMortality among methadone maintenance clients in China: a six-year cohort studyRetention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersDirectly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trialTreatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA.Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinicsImplementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence.Management of HIV infection in patients with substance use problemsHIV/AIDS and drug use in China--interactions, impacts, and issues.Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges aheadDevelopment of an electronic medical record-based clinical decision support tool to improve HIV symptom managementComorbidities among HIV-infected injection drug users in Chennai, India.Antiretroviral Therapy (ART) Use, Human Immunodeficiency Virus (HIV)-1 RNA Suppression, and Medical Causes of Hospitalization Among HIV-Infected Intravenous Drug Users in the Late ART Era.Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.Drug treatment as HIV prevention: a research updateDrug treatment as HIV prevention: expanding treatment options.Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.Modified directly observed therapy for antiretroviral therapy: a primer from the fieldMaximizing the impact of HIV prevention efforts: interventions for couples.Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugsMethadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaA pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners.Finding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in VietnamTime to act: a call for comprehensive responses to HIV in people who use drugs.Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations.Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa.Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trialInitiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapySystemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study.High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
P2860
Q27318276-5F6E55F3-4EDC-4A89-AC11-EAC2CBF198CAQ28486380-CA58A413-BA73-4143-83A9-115339A7B95DQ28534682-D71B261A-727B-45AB-9E65-91846147904DQ28537626-443F5AC7-4F43-47A0-A82F-D1918E7021B6Q28729018-78DF9B3E-BF47-420E-B587-F441AFB54A48Q30497684-DAD269FF-59AC-42D9-929D-9241C1367CE3Q30751889-9D74471E-B2F9-4A2D-9B3C-0DA60A28C2FFQ33553219-83BC0039-9440-4467-B1E2-123DD4FA7D8DQ33616453-3BD2456D-5EA1-4E1B-9006-BE4A7EE52689Q33729687-09A99D2C-0E35-4ED5-B44A-027B2E248FB3Q33821371-5845D642-D5C2-4593-9707-09E7706482ADQ33854297-F15E3883-AF80-4F3D-8D24-B41EFF5F2DC9Q34073550-71B32117-9D94-4160-9EC2-F73A215E6AE0Q34113784-86AEBAAB-C626-4F9B-901A-36A64D0ED6A8Q34119447-D8A00BCC-8405-41F9-AB67-00F2184DD7A7Q34213884-8B8DD4D1-42C1-4A5F-8C4B-BE7B3937CE22Q34624677-8454EC52-6384-4A98-AF5A-BED47AE08D7CQ34800507-99EDC780-6C3C-4D03-B081-CD34A6AC7C48Q35072003-262AEE14-B638-4CF7-9B97-2333D57FE53CQ35148360-5191F888-4418-46A4-B967-CB0376F24DF5Q35163392-9B1A88C6-A565-41F2-96E6-B2D3B5C68286Q35163396-B49A6B18-591C-4C5E-B226-0BBDD1325A38Q35164557-AFE11C70-E409-4A22-810B-CFF49ABF3061Q35633045-57BCCF53-980D-4B4F-A85E-7BA52C1A089DQ35836804-D6B20BA8-C5F6-4D9E-A177-6B6418BA4251Q36331519-DE33620B-26EF-4635-99CA-A2237BF159BAQ36356751-C98D97C5-8B39-4B47-BF38-93DF08EB7A11Q36390767-6A100D37-E8FD-4B1C-AD87-EA95D80E9609Q36706986-4FE31648-7084-45B2-B0FF-1DB4769BA212Q36779204-F8883E54-2499-442F-83CD-8469A6C9D41EQ36815377-699078B2-F2F8-48FA-B640-047C217FF93FQ36928777-27E0F612-395F-4D48-9E94-B6E81510B953Q36960952-34643FA4-4C24-4E26-A9B1-CD8F5753AF56Q37136345-4502AC3C-6160-41C7-B02C-31712B84F834Q37151302-BD8E6219-28C8-40EC-B55C-1FCB543EF139Q37163341-E223F37F-7ACB-4D4B-85F8-B6D40BFC598CQ37221321-1923C0EB-4282-4252-BF7C-A5F806EF41E7Q37224404-D9E47351-F5D0-43EE-ACAE-5269D150A293Q37349751-4B765345-41B3-438F-94D0-AF2572E52719Q37425629-138564E1-0932-47AF-9E94-F58E8B37CC4F
P2860
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Directly administered antiretr ...... concurrent comparison groups.
@en
Directly administered antiretr ...... concurrent comparison groups.
@nl
type
label
Directly administered antiretr ...... concurrent comparison groups.
@en
Directly administered antiretr ...... concurrent comparison groups.
@nl
prefLabel
Directly administered antiretr ...... concurrent comparison groups.
@en
Directly administered antiretr ...... concurrent comparison groups.
@nl
P2093
P356
P1476
Directly administered antiretr ...... concurrent comparison groups.
@en
P2093
B Anna Mullen
Gregory M Lucas
Mary E McCaul
Paul J Weidle
Richard D Moore
Shannon Hader
P304
P356
10.1086/503905
P407
P577
2006-04-28T00:00:00Z